Indonesia Lipid Market Size & Outlook, 2022-2030
Indonesia lipid market, 2018-2030 (US$M)
Related Markets
Indonesia lipid market highlights
- The Indonesia lipid market generated a revenue of USD 403.7 million in 2022 and is expected to reach USD 693.0 million by 2030.
- The Indonesia market is expected to grow at a CAGR of 7% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 403.7 million |
| Market revenue in 2030 | USD 693.0 million |
| Growth rate | 7% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Indonesia accounted for 4.3% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Indonesia lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Indonesia lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The major factor driving the growth of lipids in Indonesia is the rising consumption of dietary supplements and functional food owing to the changing habits of Indonesians to spend more on diet products that offer health benefits. Rising incidences of malnutrition in the country have augmented the demand for dietary supplements and functional food in Indonesia.
Some of the major Indonesian dietary supplement manufacturers include The Tempo Group, BASF SE, Pfizer Inc., and Glanbia PLC. Malnutrition has been a complex problem in Indonesia for many years. A majority of the Indonesian population is either affected by obesity or undernutrition.
According to the Health Minister of Indonesia, Budi Gunadi Sadikin, as of 2021, approximately 10% of children suffered from malnutrition in Indonesia, and 45% of Indonesian households are not able to afford a nutritional diet.
Reasons to subscribe to Indonesia lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Indonesia lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Indonesia lipid market , including forecasts for subscribers. This country databook contains high-level insights into Indonesia lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Indonesia lipid market size, by phase, 2018-2030 (US$M)
Indonesia Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
